The Procter & Gamble, Geratherm Medical AG and Alere Inc. are Dominating the Market for Global Fertility Testing Devices Market in 2016

The Global Fertility Testing Devices Market is segmented on the basis of product type, purchase mode and end user. The report provides data for 2015 to 2024, 2016 being the current year while 2017 to 2024.  The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Access Full Report:- http://databridgemarketresearch.com/reports/global-fertility-testing-devices-market/ 

The global fertility testing devices market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The Procter & Gamble is going to dominate the global Fertility testing devices market other major players operating in this market are Geratherm Medical AG and Alere Inc. The SPD Swiss Precision Diagnostics GMBH, Church & Dwight Co., Inc., Fairhaven Health, LLC, Prestige Brands Holdings, Inc., Hilin Life Products, Inc., Fertility Focus Limited, Babystart Ltd, Biozhena Corporation, Taidoc Technology Corporation, UEBE Medical GMBH, Accuquik, Quidel Corporation, Biomérieux among others.

PROCTER & GAMBLE:

Founded in 1837 and headquartered in Ohio, US. Proctor & Gamble is Consumer Goods Corporation. It has five segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. P&G Healthcare holds nearly 20% global market share.

Procter & Gamble has acquired a number of other companies that diversified its product line and significantly increased profits. Some of its acquisition include Folgers Coffee, Norwich Eaton Pharmaceuticals, Richardson-Vicks, Noxell (Noxzema), Shulton's Old Spice, Max Factor, the Iams Company, and others. P&G operates in approximately 70 countries worldwide. It is present in North America, Europe, Latin America, Asia Pacific, Greater China and India, Middle East and Africa (IMEA).

Recent Developments:

  1. In October 2017, P&G unveiled its new innovation in ovulation testing that pairs the accuracy of the Clearblue Ovulation Test, now with the app. The Clearblue Connected app will remind users when to test, display a user’s daily test results and let the user record details also.

Geratherm Medical AG:

Founded in 1900 and headquartered in Geschwenda, Germany. Geratherm Medical is medical technology company with the business divisions of Health Care Diagnostics, Medical Warming Systems, Cardio/Stroke and Respiratory. Geratherm Medical AG has been quoted on the stock exchange since 2000. In Healthcare segment, Geratherm Medical produces primarily medical products for end consumers. Healthcare segment include clinical thermometers, blood pressure monitors and women‘s healthcare products.

Geratherm Medical AG operates in Germany, Europe, South America, Middle East and U.S. Some of its subsidiaries include Sensor Systems GmbH, Geratherm Respiratory GmbH, Apoplex medical and others.

Alere Inc.:

Founded in 2001 and headquartered in Massachusetts, US. Alere Inc. operates in rapid diagnostics tests devices. Alere segments are focused on cardiometabolic, infectious disease, and toxicology testing. Abbott Laboratories acquired Alere which has significantly expanded Abbott's global diagnostics presence.